Aubagio ‘slows brain atrophy in RRMS patients’
Aubagio ‘slows brain atrophy in RRMS patients’
Genzyme has announced results from magnetic resonance imaging (MRI) analysis of participants in the Phase III TEMSO clinical trial showing Aubagio was able to slow the loss of brain volume (or atrophy) versus a placebo over two years in patients with relapsing-remitting multiple sclerosis (RRMS)... Read More - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 11536 Views
-
Last post by accordingnature495
-
- 0 Replies
- 1745 Views
-
Last post by NHE
-
- 0 Replies
- 1424 Views
-
Last post by NHE
-
- 4 Replies
- 1512 Views
-
Last post by NHE
-
- 0 Replies
- 1216 Views
-
Last post by NHE
-
- 0 Replies
- 1539 Views
-
Last post by NHE
-
- 0 Replies
- 2006 Views
-
Last post by frodo
-
- 0 Replies
- 2015 Views
-
Last post by NHE
-
- 0 Replies
- 1639 Views
-
Last post by NHE